Literature DB >> 23037449

Tumorigenesis: Pushing pancreatic cancer to take off.

Sarah Seton-Rogers.   

Abstract

Entities:  

Year:  2012        PMID： 23037449     DOI： 10.1038/nrc3383

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

2.  EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.

Authors:  Carolina Navas; Isabel Hernández-Porras; Alberto J Schuhmacher; Maria Sibilia; Carmen Guerra; Mariano Barbacid
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743
  2 in total
  7 in total

1.  Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine.

Authors:  Congying Chen; Wenqin Xiao; Li Huang; Ge Yu; Jianbo Ni; Lijuan Yang; Rong Wan; Guoyong Hu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy.

Authors:  Zhuangzhuang Zhang; Lijun Cheng; Jie Li; Qi Qiao; Anju Karki; Derek B Allison; Nuha Shaker; Kunyu Li; Sagar M Utturkar; Nadia M Atallah Lanman; Xiongjian Rao; Piotr Rychahou; Daheng He; Stephen F Konieczny; Chi Wang; Qing Shao; B Mark Evers; Xiaoqi Liu
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

3.  EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.

Authors:  Susanne Scheipl; Michelle Barnard; Lucia Cottone; Mette Jorgensen; David H Drewry; William J Zuercher; Fabrice Turlais; Hongtao Ye; Ana P Leite; James A Smith; Andreas Leithner; Peter Möller; Silke Brüderlein; Naomi Guppy; Fernanda Amary; Roberto Tirabosco; Sandra J Strauss; Nischalan Pillay; Adrienne M Flanagan
Journal:  J Pathol       Date:  2016-05-31       Impact factor: 7.996

4.  Genetic GIScience: Toward a Place-Based Synthesis of the Genome, Exposome, and Behavome.

Authors:  Geoffrey M Jacquez; Clive E Sabel; Chen Shi
Journal:  Ann Assoc Am Geogr       Date:  2015

5.  Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.

Authors:  Xianglan Jin; Yang Sun; Haiyan Yang; Ji Li; Shuangni Yu; Xiaoyan Chang; Zhaohui Lu; Jie Chen
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  ADAM8 as a drug target in pancreatic cancer.

Authors:  Uwe Schlomann; Garrit Koller; Catharina Conrad; Taheera Ferdous; Panagiota Golfi; Adolfo Molejon Garcia; Sabrina Höfling; Maddy Parsons; Patricia Costa; Robin Soper; Maud Bossard; Thorsten Hagemann; Rozita Roshani; Norbert Sewald; Randal R Ketchem; Marcia L Moss; Fred H Rasmussen; Miles A Miller; Douglas A Lauffenburger; David A Tuveson; Christopher Nimsky; Jörg W Bartsch
Journal:  Nat Commun       Date:  2015-01-28       Impact factor: 14.919

Review 7.  The potential roles of exosomes in pancreatic cancer initiation and metastasis.

Authors:  Wei Sun; Ying Ren; Zaiming Lu; Xiangxuan Zhao
Journal:  Mol Cancer       Date:  2020-09-02       Impact factor: 27.401
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.